Comparison 1. EGFR tyrosine kinase inhibitor (TKI) compared to observation alone for maintenance treatment of epithelial ovarian cancer after first‐line chemotherapy.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Overall survival | 1 | Hazard Ratio (Random, 95% CI) | Subtotals only | |
2 Progression‐free survival | 1 | Hazard Ratio (Random, 95% CI) | Subtotals only |